AVITA Medical, Inc. Cash Flow Statement
RCEL|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
AVITA Medical, Inc. used $49M in operating cash flow and negative free cash flow of $58M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | -$61.8M | -$35.4M | -$26.7M | -$26.6M | -$25.1M | -$12.7M |
| Depreciation & Amortization | $1.1M | $632.0K | $568.0K | $715.0K | $269.0K | $110.0K |
| Operating Cash Flow | -$48.9M | -$38.0M | -$19.1M | -$25.9M | -$19.3M | -$13.0M |
| Capital Expenditures | $9.2M | $1.4M | $452.0K | $894.0K | $1.0M | $365.0K |
| Free Cash Flow | -$58.1M | -$39.4M | -$19.5M | -$26.8M | -$20.3M | -$13.3M |
| FCF Margin | -90.4% | -78.6% | -56.8% | -91.7% | -370.3% | -1434.3% |